Your browser doesn't support javascript.
loading
Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode.
Hu, Lu; Sun, Yang; Liu, Shun; Erb, Hannah; Singh, Alka; Mao, Junhao; Luo, Xuelian; Wu, Xu.
Afiliación
  • Hu L; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.
  • Sun Y; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.
  • Liu S; Departments of Pharmacology & Biophysics, University of Texas Southwestern Medical Center, Dallas, United States.
  • Erb H; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.
  • Singh A; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States.
  • Mao J; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States.
  • Luo X; Departments of Pharmacology & Biophysics, University of Texas Southwestern Medical Center, Dallas, United States.
  • Wu X; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, United States.
Elife ; 112022 11 18.
Article en En | MEDLINE | ID: mdl-36398861

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción de Dominio TEA / Antineoplásicos Límite: Humans Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción de Dominio TEA / Antineoplásicos Límite: Humans Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
...